Genetically engineered human neural stem cells for brain repair in neurological diseases

Brain and Development

Volumn 29, Issue 4, 2007, Pages 193-201

  Kim, Seung U ^a,b  

^a Ajou University School of Medicine   (South Korea)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Brain tumor; Cell therapy; F3 human NSCs; Human neural stem cell; Huntington disease; Lysosomal storage disease; Parkinson disease; Stroke

Indexed keywords

RETROVIRUS VECTOR;

AMYOTROPHIC LATERAL SCLEROSIS; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; GENETIC ENGINEERING; GLIA CELL; HUMAN; HUNTINGTON CHOREA; LYSOSOME STORAGE DISEASE; MULTIPLE SCLEROSIS; NERVE CELL; NEURAL STEM CELL; NEUROLOGIC DISEASE; NONHUMAN; ONCOGENE MYC; PARKINSON DISEASE; REGENERATIVE MEDICINE; REVIEW; SPINAL CORD INJURY; STROKE;

ANIMALS; BRAIN INJURIES; GENETIC ENGINEERING; HUMANS; NERVOUS SYSTEM DISEASES; NEURONS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 33847120763     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2006.07.012     Document Type: Review

References (86)

1. McKay R.G. Stem cells in the central nervous system. Science 276 (1997) 66-71
2. Gage F.H. Mammalian neural stem cells. Science 287 (2000) 1433-1438
3. Temple S. The development of neural stem cells. Nature 414 (2001) 112-117
4. Gottlieb D.I. Large scale sources of neural stem cells. Annu Rev Neurosci 25 (2002) 381-407
5. Snyder E.Y. Grafting immortalized neurons to the CNS. Curr Opin Neurobiol 4 (1994) 742-751
6. Raynolds B.A., and Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic precursor is a stem cell. Dev Biol 175 (1996) 1-13
7. Whittemore S.R., and Snyder E.Y. Physiological relevance and functional potential of central nervous system-derived cell lines. Mol Neurobiol 12 (1996) 13-38
8. Martinez-Serrano A., and Bjorklund A. Immortalized neural progenitor cells for CNS gene transfer and repair. Trends Neurosci 20 (1997) 530-538
9. Brustle O., Spiro A., Karram K., Choudhary K., Okabe S., Mckay R.D., et al. In vitro generated neural precursors participate in mammalian brain development. Proc Natl Acad Sci USA 94 (1997) 14809-14814
10. Brustle O., and McKay R.G. Neuronal progenitors as tools for cell replacement in the nervous system. Curr Opin Neurobiol 6 (1996) 688-695
11. Buc-Caron M.H. Neuroepithelial progenitor cells explanted from human fetal brain proliferate and differentiate in vitro. Neurobiol Dis 2 (1995) 37-47
12. Eriksson P., Perfilieva E., Bjork T., Alborn A.M., Nordborg C., Peterson D.A., et al. Neurogenesis in the adult human hippocampus. Nat Med 4 (1998) 1313-1317
13. Flax J.D., Aurora S., Yang C., Simonin C., Wills A.M., Billinghurst L.L., et al. Engraftable human neural stem cells respond to developmental clues, replace neurons, and express foreign genes. Nat Biotech 16 (1998) 1033-1039
14. Sah D.W., Ray J., and Gage F. Bipotent progenitor cell lines from the human CNS. Nat Biotech 15 (1997) 574-580
15. Villa A., Snyder E.Y., Vescovi A., and Martinez A. Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS. Exp Neurol 161 (2000) 67-84
16. Kim S.U. Human neural stem cells genetically modified for brain repair in neurological diseases. Neuropathology 24 (2004) 159-171
17. Raynolds B.A., and Weiss S. Generation of neurons and astrocytes from isolated cells from the adult mammalian central nervous system. Science 255 (1992) 1707-1710
18. Uchida N., Buck D.W., He D., Reitsma M.J., Masek M., Phan T.V., et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 97 (2000) 14720-14725
19. Snyder E.Y., Deitcher D.L., and Walsh C. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68 (1992) 33-51
20. Hoshimaru M., Ray J., Sah D.W., and Gage F.H. Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene. Proc Natl Acad Sci USA 93 (1996) 1518-1523
21. Renfranz P.J., Cunningham M., and McKay R. Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain. Cell 66 (1991) 713-729
22. Cho T., Bae J., Choi H.B., Kim S.S., McLarnon J.G., Suh H., et al. Human neural stem cells: Electrophysiological properties of voltage-gated ion channels. Neuroreport 13 (2002) 1447-1452
23. Ryu J.K., Choi H.B., Hatori K., Heisel R.L., Pelech S.L., McLarnon J.G., et al. Adenosine triphosphate induces proliferation of human neural stem cells: Role of calcium and p70 ribosomal protein S6 kinase. J Neurosci Res 72 (2003) 352-362
24. Chu K., Kim M.H., Jeong S.W., Kim S.U., and Yoon B.W. Human neural stem cells can migrate, differentiate and integrate after intravenous transplantation in adult rats with transient forebrain ischemia. Neurosci Lett 343 (2003) 129-133
25. Chu K., Kim M., Park K.I., Jeong S.W., Park H.K., Jung K.H., et al. Human neural stem cells improve sensorymotor deficits in the adult rat brain with experimental focal ischemia. Brain Res 1016 (2004) 145-153
26. Jeong S.W., Chu K., Jung K.H., Kim S.U., Kim M., Roh J.K., et al. Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke 34 (2003) 2258-2263
27. Ryu J.K., Kim J., Cho S.J., Hatori K., Nagai A., Choi H.B., et al. Proactive transplantation of human neural stem cells prevents cell death of striatal neurons in rat model of Huntington disease. Neurobiol Dis 16 (2004) 68-77
28. Lee S.T., Chu K., Park J.E., Lee L., Kang L., Kim S.U., et al. Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model. Neurosci Res 52 (2005) 243-249
29. Kim S.U., Park I.H., Kim T.H., Kim K.S., Choi H.B., Hong S.H., et al. Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease. Neuropathology 26 (2006) 129-140
30. Meng X.L., Shen J.S., Ohashi T., Maeda H., Kim S.U., Eto Y., et al. Brain transplantation of genetically engineered human neural stem cells transduced with beta-glucuronidase globally corrects lysosomal storage and brain lesions in mucopolysaccharidosis VII mice. J Neurosci Res 74 (2003) 266-277
31. Nieto M., Schuurmans C., Britz O., and Guillemot F. Neural bHLH genes control the neuronal versus glial fate decision in cortical progenitors. Neuron 29 (2001) 401-413
32. Caldwell M.A., He X., Wilkie N., Pollack S., Marshall G., Wafford K.A., et al. Growth factors regulate the survival and fate of cells derived from human neurosphere. Nat Biotech 19 (2001) 475-479
33. Daadi M.M., and Weiss S. Generation of tyrosine hydroxylase producing neurons from precursors of the embryonic and adult forebrain. J Neurosci 19 (1999) 4484-4497
34. Tanigaki K., Nogaki F., Takahashi J., Tashiro K., Kurooka H., Honjo T., et al. Notch1 and Notch3 instructively restrict bFGF-responsive multipotent neural progenitor cells to an astroglial fate. Neuron 29 (2001) 45-55
35. Lu Q.R., Yuk D., Alberta J.A., Zhu Z., Pawlitzky I., and Chan J. Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 25 (2000) 317-329
36. Zhou Q., Wang S., and Anderson D.J. The bHLH transcription factors Olig2 and Olig1 couple neuronal and glial subtype specification. Neuron 25 (2000) 331-343
37. Meikle P.J., Hopwood J.J., Clague A.E., and Carey W.F. Prevalence of lysosomal storage disorders. J Am Med Ass 281 (1999) 249-254
38. Sly W.S., and Vogler C. Brain-directed gene therapy for lysosomal storage disease: going well beyond the blood-brain barrier. Proc Natl Acad Sci USA 99 (2002) 5760-5762
39. Snyder E.Y., Taylor R.M., and Wolfe J.H. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374 (1995) 367-370
40. Taylor R.M., and Wolfe J.H. Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of beta-glucuronidase. Nat Med 3 (1997) 771-774
41. Kosuga M., Sasaki K., Tanabe A., Li X.K., Okawa H., Ogino I., et al. Engraftment of genetically engineered amniotic epithelial cells corrects lysosomal storage in multiple areas of the brain in MPS VII mice. Mol Ther 3 (2001) 139-148
42. Savitz S.I., Rosenbaum D.M., Dinsmore J.H., Wechsler L.R., and Caplan L.R. Cell transplantation for stroke. Ann Neurol 52 (2002) 266-275
43. Chen J., Li Y., Wang L., Lu M., and Chopp M. Caspase inhibition of Z-VAD increases the survival of grafted bone marrow cells and improves functional outcome after MCOA in rats. J Neurol Sci 190 (2002) 17-24
44. Zhao L.R., Duan W.M., Reyes M., Keene C.D., Verfaille C.M., Low W.C., et al. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischmica brain of rats. Exp Neurol 174 (2002) 11-20
45. Onifer S.M., and Low W.C. Spatial memory deficit resulting from ischemia-induced damage to the hippocampus is ameliorated by intra-hippocampal transplants of fetal hippocampal neurons. Prog Brain Res 82 (1990) 359-366
46. Sinden J.D., Rashid-Doubell F., Kershaw T.R., Nelson A., Chadwick A., Jat P.S., et al. Recovery of spatial learning by grafts of a conditionally immortalized hippocampal neuroepithelial cell line into the ischemia-lesioned hippocampus. Neuroscience 81 (1997) 599-608
47. Veizovic T., Beech J.S., Stroemer R.P., Watson W.P., and Hodges H. Resolution of stroke deficits following contralateral grafts of conditionally immortalized neuroepithelial stem cells. Stroke 32 (2001) 1012-1019
48. Modo M., Stroemer R.P., Tang E., Patel S., and Hodges H. Effects of implantation site of stem cell grafts on behavioral recovery from stroke damage. Stroke 33 (2002) 2270-2278
49. Chen J., Sanberg P.R., Li Y., Wang L., Lu M., Willing A.E., et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32 (2001) 2682-2688
50. Borlongan C.V., Tajima Y., Trojanowski J.Q., Lee V.M., and Sanberg P.R. Transplantation of cryopreserved human embryonic carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp Neurol 149 (1998) 310-321
51. Saporta S., Borlongan C.V., and Sanberg P.R. Neural transplantation of human neuroteratocarcinoma neurons into ischemic rats. A quantitative dose-response analysis of cell survival and behavioral recovery. Neuroscience 91 (1999) 519-525
52. Kondziolka D., Wechsler L., Goldstein S., Meltzer C., Thulborn K.R., Gebel J., et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55 (2000) 565-569
53. Bang O.Y., Lee J.S., Lee P.H., and Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57 (2005) 874-882
54. Gebel J.M., and Broderick J.P. Intracerebral hemorrhage. Neurol Clin 18 (2000) 419-438
55. NINDS ICH Workshop Participants. Priorities for clinical research in intracerebral hemorrhage: report from a National Institute of Neurological Disorders and Stroke workshop. Stroke 36 (2005) 23-41
56. Ishibashi S., Sakaguchi M., Kuroiwa T., Yamasaki M., Kanemura Y., Shizuko I., et al. Human neural stem/progenitor cells, expanded in long-term neurosphere culture, promote functional recovery after focal ischemia in Mongolian gerbils. J Neurosci Res 78 (2004) 215-223
57. Leker R.R., and McKay R.D. Using endogenous neural stem cells to enhance recovery from ischemic brain injury. Curr Neurovasc Res 1 (2004) 421-427
58. Lindvall O., Sawle G., and Widner H. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 35 (1994) 172-180
59. Olanow C.W., Kordower J.H., and Freeman T. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 19 (1996) 102-109
60. Kordower J.J., Freeman T.B., and Snow B.J. Neuropathological evidence of graft survival and striatal reinnervations after the transplantation of fetal mesencephalic tissue in a patients with Parkinson's disease. N Eng J Med 2717 (1997) 1118-1124
61. Fischer L.J., Jinnah H.A., Kale L.C., Higgins G.A., and Gage F.H. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-dopa. Neuron 6 (1991) 371-380
62. During M.J., Naegele J.R., and O'Malley K.L. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266 (1994) 1399-1403
63. Levivier M., Przedborski S., Bencsis C., and Kang U.J. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J Neurosci 15 (1995) 7810-7820
64. Takayama H., Ray J., and Raymon H. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nat Med 1 (1995) 53-58
65. Bencsics C., Wachtel S.R., Milstein S., Hatakeyama K., Becker J.B., Kang U.J., et al. Double transduction with GTP-cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of l-DOPA by primary fibroblasts. J Neurosci 16 (1996) 4449-4456
66. Kim S.U., Lee M.A., Jin B.K., Ryu J.K., et al. Generation of immortalized human neural stem cells and brain transplantation in animal models of Parkinson's disease. Ann Neurol 40 (2000) 222
67. Lee M.A., Lee H.S., Cho K.G., Jin B.K., Sohn S., Lee Y.S., et al. Overexpression of midbrain-specific transcription factor Nurr1 modifies susceptibility of neural stem cells to neurotoxins. Neurosci Lett 333 (2002) 74-78
68. Greenamyre J.T., and Shoulson I. Huntington disease. In: Calne D. (Ed). Neurodegenerative disease (1994), W.B. Saunders, Philadelphia 5-704
69. Harper P.S. Huntington's disease (1996), W.B. Saunders, Philadelphia
70. Bachoud-Levi A.C., Remy P., Nguen J.P., Brugieres P., Lefaucheur J.P., Bourdet C., et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 356 (2000) 1975-1979
71. Nakao N., and Itakura T. Fetal tissue transplants in animal models of Huntington's disease: The effects on damaged neuronal circuitry and behavioral deficits. Prog Neurobiol 61 (2000) 313-338
72. Dunnett S.B., Carter R.J., Watts C., Torres E.M., Mahal A., and Mangiarini L. Striatal transplantation in a transgenic mouse model of Huntington's disease. Exp Neurol 154 (1998) 31-40
73. Freeman T.B., Cicchetti F., Hauser R.A., Deacon T.W., Li X.J., and Hersch S.M. Transplanted fetal striatum in Huntington's disease: Phenotypic development and lack of pathology. Proc Natl Acad Sci USA 97 (2000) 13877-13882
74. Bjorklund A., and Lindvall O. Cell replacement therapies for central nervous system disorders. Nat Neurosci 3 (2000) 537-544
75. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (1993) 971-983
76. Harris G.J., Codori A.M., Lewis R.F., Schmidt E., Bedi A., Brandt J., et al. Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease. Brain 122 (1999) 1667-1678
77. Thieben M.J., Duggins A.J., Good C.D., Gomes L., Mahant N., Richards F., et al. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 125 (2002) 1815-1828
78. Beal M.F., Brouillet E., Jenkins B.G., Ferrante R.J., Kowall N.W., Miller J.M., et al. Neurochemical and histologic characterization of triatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13 (1993) 4181-4192
79. Alston T.A., Mela L., and Bright H.J. 3-Nitropropionic acid, the toxic substance of Indiuofera, is a suicide inactivator of succinic dehydrogenase. Proc Natl Acad Sci USA 74 (1977) 3767-3771
80. Bemelmans A.P., Horellou P., Pradier L., Brunet I., Colin P., and Mallet J. Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington disease, as demonstrated by adenoviral gene transfer. Hum Gene Ther 10 (1999) 2987-2997
81. Perez-Navarro E., Canudas A.M., Akerund P., Alberch J., and Arenas E. Brain-derived neurotrophic factor, NT-3 and NT-3/4 prevent the death of striatal projection neurons in rodent model of Huntington's disease. J Neurochem 75 (2000) 2190-2199
82. Black P.M., and Loeffler J. Cancer of the nervous system (1997), Blackwell, Oxford
83. Aboody K., Brown A., Rainov N., Bower K.A., Liu S., Yang W., et al. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc Natl Acad Sci USA 97 (2000) 12846-12851
84. Kim S.K., Cargioli T.G., Machluf M., Yang W., Sun Y., Al-Hashem R., et al. PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Cancer Res 11 (2005) 5965-5970
85. Bello L., Lucini V., Carrabba G., Giussani C., Machluf M., Pluderi M., et al. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metaloproteinase-2. Cancer Res 61 (2001) 8730-8736
86. Aboody K., Garcia E., Kim S.U., et al. Human neural stem cells target human primary and metastatic cancers in animal models: Potential therapeutic applications. Proc Int Soc Stem Cell Res 2 (2004) 542